BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15542284)

  • 1. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
    Kaye DM; Smirk B; Finch S; Williams C; Esler MD
    J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
    Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
    J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of norepinephrine release in adriamycin-induced heart failure in rabbits: role of presynaptic alpha 2-adrenoceptors and presynaptic angiotensin II receptors.
    Minatoguchi S; Majewski H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):438-45. PubMed ID: 7515988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
    Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
    Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction.
    Gilsbach R; Brede M; Beetz N; Moura E; Muthig V; Gerstner C; Barreto F; Neubauer S; Vieira-Coelho MA; Hein L
    Cardiovasc Res; 2007 Sep; 75(4):728-37. PubMed ID: 17597596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
    Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
    Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of alpha-adrenergic receptor blockade on peripheral vasoconstriction induced by the cold pressor test. Evidence for functional integrity of alpha 1 and alpha 2 adrenergic receptors in patients with congestive heart failure].
    Maione A; Rapacciuolo A; Esposito G; Di Lorenzo E; Ceravolo R; Indolfi C; Chiariello M
    Cardiologia; 1992 Dec; 37(12):839-45. PubMed ID: 1363884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.
    Shin J; Lobmeyer MT; Gong Y; Zineh I; Langaee TY; Yarandi H; Schofield RS; Aranda JM; Hill JA; Pauly DF; Johnson JA
    Am J Cardiol; 2007 Jan; 99(2):250-5. PubMed ID: 17223428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between expressions of beta1-, beta2-, beta3-adrenoceptor mRNA of myocardium and cardiac function in patients with heart failure].
    Li ZK; Zhu SJ; Yu LJ; Tian Y; Zhou YZ; Wang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):351-3. PubMed ID: 15932670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
    Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
    Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic neuronal regulation of the heart in aging and heart failure.
    Kaye D; Esler M
    Cardiovasc Res; 2005 May; 66(2):256-64. PubMed ID: 15820194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
    Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure.
    Zhang L; Hu D; Li J; Wu Y; Liu X; Yang X
    Chin Med J (Engl); 2002 Aug; 115(8):1127-31. PubMed ID: 12215275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.